251 related articles for article (PubMed ID: 12024010)
1. Regulation of c-myc mRNA decay by translational pausing in a coding region instability determinant.
Lemm I; Ross J
Mol Cell Biol; 2002 Jun; 22(12):3959-69. PubMed ID: 12024010
[TBL] [Abstract][Full Text] [Related]
2. CRD-BP shields c-myc and MDR-1 RNA from endonucleolytic attack by a mammalian endoribonuclease.
Sparanese D; Lee CH
Nucleic Acids Res; 2007; 35(4):1209-21. PubMed ID: 17264115
[TBL] [Abstract][Full Text] [Related]
3. Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs.
Weidensdorfer D; Stöhr N; Baude A; Lederer M; Köhn M; Schierhorn A; Buchmeier S; Wahle E; Hüttelmaier S
RNA; 2009 Jan; 15(1):104-15. PubMed ID: 19029303
[TBL] [Abstract][Full Text] [Related]
4. CRD-BP: a c-Myc mRNA stabilizing protein with an oncofetal pattern of expression.
Ioannidis P; Mahaira L; Papadopoulou A; Teixeira MR; Heim S; Andersen JA; Evangelou E; Dafni U; Pandis N; Trangas T
Anticancer Res; 2003; 23(3A):2179-83. PubMed ID: 12894594
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of c-myc expression in cells by targeting an RNA-protein interaction using antisense oligonucleotides.
Coulis CM; Lee C; Nardone V; Prokipcak RD
Mol Pharmacol; 2000 Mar; 57(3):485-94. PubMed ID: 10692488
[TBL] [Abstract][Full Text] [Related]
6. Targeted knockdown of the RNA-binding protein CRD-BP promotes cell proliferation via an insulin-like growth factor II-dependent pathway in human K562 leukemia cells.
Liao B; Patel M; Hu Y; Charles S; Herrick DJ; Brewer G
J Biol Chem; 2004 Nov; 279(47):48716-24. PubMed ID: 15355996
[TBL] [Abstract][Full Text] [Related]
7. Isolation of ribosome bound nascent polypeptides in vitro to identify translational pause sites along mRNA.
Jha SS; Komar AA
J Vis Exp; 2012 Jul; (65):. PubMed ID: 22806127
[TBL] [Abstract][Full Text] [Related]
8. Developmental regulation of CRD-BP, an RNA-binding protein that stabilizes c-myc mRNA in vitro.
Leeds P; Kren BT; Boylan JM; Betz NA; Steer CJ; Gruppuso PA; Ross J
Oncogene; 1997 Mar; 14(11):1279-86. PubMed ID: 9178888
[TBL] [Abstract][Full Text] [Related]
9. The c-myc coding region determinant-binding protein: a member of a family of KH domain RNA-binding proteins.
Doyle GA; Betz NA; Leeds PF; Fleisig AJ; Prokipcak RD; Ross J
Nucleic Acids Res; 1998 Nov; 26(22):5036-44. PubMed ID: 9801297
[TBL] [Abstract][Full Text] [Related]
10. Suppression of Ribosomal Pausing by eIF5A Is Necessary to Maintain the Fidelity of Start Codon Selection.
Manjunath H; Zhang H; Rehfeld F; Han J; Chang TC; Mendell JT
Cell Rep; 2019 Dec; 29(10):3134-3146.e6. PubMed ID: 31801078
[TBL] [Abstract][Full Text] [Related]
11. Systematic analysis of the contribution of c-myc mRNA constituents upon cap and IRES mediated translation.
Meristoudis C; Trangas T; Lambrianidou A; Papadopoulos V; Dimitriadis E; Courtis N; Ioannidis P
Biol Chem; 2015 Dec; 396(12):1301-13. PubMed ID: 26351916
[TBL] [Abstract][Full Text] [Related]
12. mTORC2 deploys the mRNA binding protein IGF2BP1 to regulate c-MYC expression and promote cell survival.
Lambrianidou A; Sereti E; Soupsana K; Komini C; Dimas K; Trangas T
Cell Signal; 2021 Apr; 80():109912. PubMed ID: 33388443
[TBL] [Abstract][Full Text] [Related]
13. CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling.
Noubissi FK; Elcheva I; Bhatia N; Shakoori A; Ougolkov A; Liu J; Minamoto T; Ross J; Fuchs SY; Spiegelman VS
Nature; 2006 Jun; 441(7095):898-901. PubMed ID: 16778892
[TBL] [Abstract][Full Text] [Related]
14. 8q24 Copy number gains and expression of the c-myc mRNA stabilizing protein CRD-BP in primary breast carcinomas.
Ioannidis P; Mahaira L; Papadopoulou A; Teixeira MR; Heim S; Andersen JA; Evangelou E; Dafni U; Pandis N; Trangas T
Int J Cancer; 2003 Mar; 104(1):54-9. PubMed ID: 12532419
[TBL] [Abstract][Full Text] [Related]
15. Identification of Apurinic/apyrimidinic endonuclease 1 (APE1) as the endoribonuclease that cleaves c-myc mRNA.
Barnes T; Kim WC; Mantha AK; Kim SE; Izumi T; Mitra S; Lee CH
Nucleic Acids Res; 2009 Jul; 37(12):3946-58. PubMed ID: 19401441
[TBL] [Abstract][Full Text] [Related]
16. CRD-BP/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells.
Ioannidis P; Mahaira LG; Perez SA; Gritzapis AD; Sotiropoulou PA; Kavalakis GJ; Antsaklis AI; Baxevanis CN; Papamichail M
J Biol Chem; 2005 May; 280(20):20086-93. PubMed ID: 15769738
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of an mRNA-binding protein in human colorectal cancer.
Ross J; Lemm I; Berberet B
Oncogene; 2001 Oct; 20(45):6544-50. PubMed ID: 11641779
[TBL] [Abstract][Full Text] [Related]
18. Translational Control through Differential Ribosome Pausing during Amino Acid Limitation in Mammalian Cells.
Darnell AM; Subramaniam AR; O'Shea EK
Mol Cell; 2018 Jul; 71(2):229-243.e11. PubMed ID: 30029003
[TBL] [Abstract][Full Text] [Related]
19. Purification and properties of a protein that binds to the C-terminal coding region of human c-myc mRNA.
Prokipcak RD; Herrick DJ; Ross J
J Biol Chem; 1994 Mar; 269(12):9261-9. PubMed ID: 8132663
[TBL] [Abstract][Full Text] [Related]
20. C-Myc 5' untranslated region contains an internal ribosome entry segment.
Stoneley M; Paulin FE; Le Quesne JP; Chappell SA; Willis AE
Oncogene; 1998 Jan; 16(3):423-8. PubMed ID: 9467968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
